Sargent Bickham Lagudis LLC Edwards Lifesciences Corp Transaction History

Sargent Bickham Lagudis LLC

$1.22 Billion
Q4 2022

A detailed history of Sargent Bickham Lagudis LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 9,523 shares of EW stock, worth $705,844. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,523

Previous 9,523 -0.0%

Holding current value

$705,844

Previous $787,000 9.78%

% of portfolio

0.06%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$82.37 - $107.29 $82 - $107	1 Added 0.01%	9,523 $787,000
Q2 2022 Jul 13, 2022	BUY	$86.5 - $128.27 $20,241 - $30,015	234 Added 2.52%	9,522 $905,000
Q1 2022 Apr 27, 2022	SELL	$101.96 - $128.34 $61,175 - $77,004	-600 Reduced 6.07%	9,288 $1.09 Million
Q3 2021 Nov 05, 2021	SELL	$102.91 - $122.75 $88,914 - $106,056	-864 Reduced 8.04%	9,888 $1.12 Million
Q2 2021 Jul 19, 2021	SELL	$83.84 - $104.76 $4,024 - $5,028	-48 Reduced 0.44%	10,752 $1.11 Million
Q4 2020 May 24, 2021	SELL	$71.69 - $91.23 $13,979 - $17,789	-195 Reduced 1.77%	10,800 $903,000
Q2 2020 Sep 07, 2021	BUY	$57.54 - $76.95 $421,768 - $564,043	7,330 Added 200.0%	10,995 $760,000
Q1 2020 Sep 07, 2021	BUY	$52.41 - $81.0 $104 - $162	2 Added 0.05%	3,665 $691,000
Q1 2019 Sep 13, 2021	BUY	$47.89 - $64.05 $4,693 - $6,276	98 Added 2.75%	3,663 $701,000
Q2 2018 Sep 13, 2021	BUY	$42.45 - $51.3 $25,470 - $30,780	600 Added 20.24%	3,565 $519,000
Q1 2018 Sep 13, 2021	SELL	$37.19 - $47.45 $32,466 - $41,423	-873 Reduced 22.75%	2,965 $414,000
Q4 2017 Sep 13, 2021	BUY	$33.79 - $39.39 $2,736 - $3,190	81 Added 2.16%	3,838 $433,000
Q3 2017 Sep 13, 2021	SELL	$36.29 - $38.83 $5,262 - $5,630	-145 Reduced 3.72%	3,757 $411,000
Q2 2017 Sep 13, 2021	BUY	N/A	176 Added 4.72%	3,902 $461,000
Q4 2016 Sep 13, 2021	SELL	N/A	-47 Reduced 1.25%	3,726 $349,000
Q3 2016 Sep 13, 2021	SELL	N/A	-60 Reduced 1.57%	3,773 $455,000
Q2 2016 Sep 07, 2021	BUY	N/A	47 Added 1.24%	3,833 $382,000
Q1 2016 Sep 07, 2021	BUY	N/A	3,786	3,786 $334,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Account

Sargent Bickham Lagudis LLC Edwards Lifesciences Corp Transaction History